Title:The Validity of Mobile Applications to Facilitate Patient Care Provided to
Cancer Patients: Opportunities and Limitations
Volume: 17
Issue: 2
Author(s): Haneen Amawi*, Sayer Al-Azzam, Tasnim Alzanati , Neveen Altamimi, Alaa Hammad , Karem H. Alzoubi , Charles R. Ashby and Amit K. Tiwari
Affiliation:
- Department of Pharmacy Practice, Faculty of Pharmacy, Yarmouk University, Irbid 22110, Jordan
Keywords:
Cancer apps, health services, cancer Care, google play, health Apps, smartphone mobile.
Abstract:
Background: The use of health-related applications (apps) on smartphones has become
widespread. This is especially of value during the ongoing SAR-COV-2 pandemic, where accessibility
to health care services has been greatly limited. Patients with free access to apps can obtain
information to improve their understanding and management of health issues. Currently, there are
cancer-related apps available on iPhones and androids. However, there are no guidelines to control
these apps and ensure their quality. Furthermore, these apps may significantly modify the patients’
perception and knowledge about drug-related health services.
Objectives: The aim of this study was to assess the convenience, quality, safety and efficacy of
apps for cancer patient care.
Methods: The study was conducted by searching all apps related to cancer care on both Google
Play Store and Apple iTunes Store. A detailed assessment was then performed using the mobile application
rating scale (MARS) and risk assessment tools.
Results: The results indicated that on a scale from 1-5, 47% of the apps were rated ≥ 4. The MARS
assessment of the apps yielded an overall quality rating of 3.38 ± 0.9 (mean ± SD). The visual appeal
of the app was found to have a significant effect on app functionality and user engagement.
The potential benefits of these apps come with challenges and limitations. Patents related to smartphone
applications targeting patients were also discussed.
Conclusion: We recommend a greater emphasis toward producing evidence-based apps. These
apps should be rigorously tested, evaluated and updated by experts, particularly clinical pharmacists.
Also, these apps may alter patient attitudes toward services provided by physicians and pharmacists.
Finally, these apps should not replace in-person interactive health services.